Galapagos CEO Paul Stoffels to step down, former Neumora chief to lead spinout

Lei Lei Wu

News Reporter

Paul Stoffels joined Galapagos to turn it around three years ago. But after a series of unsuccessful studies, pipeline changes and a bumpy quest into …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Galapagos CEO Paul Stoffels to step down, former Neumora chief to lead spinout

Lei Lei Wu

News Reporter

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Vaccine biotechs say they’ve been told to stop next-gen Covid work under a Biden-era project

Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffs

Updated: Roche’s $50B US investment includes previous build announcements

As the XBI suffers, Q1 shows a few comforting signs of underlying stability

Recent FDA staff cuts to delay drug hearing decision by months, agency tells Vanda

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Gala­pa­gos CEO Paul Stof­fels to step down, for­mer Neumo­ra chief to lead spin­out

News Reporter

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Galapagos CEO Paul Stoffels to step down, former Neumora chief to lead spinout